Cargando…
Comparative outcomes of combined corticosteroid and remdesivir therapy with corticosteroid monotherapy in ventilated COVID-19 patients
Remdesivir (RDV) reduces time to clinical improvement in hospitalized COVID -19 patients requiring supplemental oxygen. Dexamethasone improves survival in those requiring oxygen support. Data is lacking on the efficacy of combination therapy in patients on mechanical ventilation. We analyzed for com...
Autores principales: | Mandadi, Subhadra, Pulluru, Harish, Annie, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865672/ https://www.ncbi.nlm.nih.gov/pubmed/35196344 http://dx.doi.org/10.1371/journal.pone.0264301 |
Ejemplares similares
-
Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients
por: Coelho, Luís, et al.
Publicado: (2023) -
Comparison of combined leflunomide and low-dose corticosteroid therapy with full-dose corticosteroid monotherapy for progressive IgA nephropathy
por: Min, Lulin, et al.
Publicado: (2017) -
Comparative study of corticosteroid monotherapy, and TNF inhibitors with or without corticosteroid in patients with refractory entero-Behcet’s disease
por: Miyagawa, Ippei, et al.
Publicado: (2019) -
Remdesivir and systemic corticosteroids for the treatment of COVID-19: A Bayesian re-analysis
por: Lee, Todd C., et al.
Publicado: (2021) -
Acute Fibrinous and Organizing Pneumonia with Myelodysplastic Syndrome: Corticosteroid Monotherapy Led to Successful Ventilator Weaning
por: Yamamoto, Mari, et al.
Publicado: (2016)